SCHEMBL107060

SCHEMBL107060

O=C(Cl)c1ccc(Cl)cc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.68
TSHR P16473 1/20 0.68
CASP1 P29466 1/20 0.68
MAPT P10636 3/20 0.64
KDM4E B2RXH2 1/20 0.64
ALDH1A1 P00352 5/20 0.61
MAPK1 P28482 1/20 0.61
HIF1A Q16665 1/20 0.61
ERCC5 P28715 1/20 0.53
FEN1 P39748 1/20 0.53
SRD5A2 P31213 1/20 0.53
POLB P06746 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
THRB P10828 1/20 0.50
RECQL P46063 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TP53 P04637 1/20 0.50
FLT1 P17948 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732135 1.00 SMN1; SMN2 (0.68) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL9823673 0.84 SMN1; SMN2 (0.50) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL180845 0.83 SMN1; SMN2 (0.71) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL30185351 0.83 SMN1; SMN2 (0.71) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL195020 0.83 SMN1; SMN2 (0.71) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL8065539 0.83 SMN1; SMN2 (0.71) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL654794 0.83 ALDH1A1 (0.52) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL19998346 0.81 SMN1; SMN2 (0.68) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL111279 0.81 TSHR (1.00) SMN1; SMN2TSHRCASP1MAPTKDM4E
SCHEMBL699001 0.81 ALDH1A1 (0.68) SMN1; SMN2TSHRCASP1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1924 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12161116-B1 Ethyl-2-{[(2,4-dichlorobenzoyl carbamothioyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as an eco-friendly insecticidal agent against Spodoptera littoralis (boisd.) King Faisal University (SA) 2024-12-10 US claimed
CN-113582836-B Method for synthesizing 2, 4-dichlorobenzoyl chloride 江苏聚由新材料科技有限公司 2024-12-03 CN claimed
CN-109384699-B On-line full continuous flow production process for directly preparing organic peroxide by taking hydrogen peroxide as raw material 上海惠和化德生物科技有限公司 2024-10-22 CN claimed
CN-118255720-A Method for preparing imidazole ethanol 启农生物科技(北京)有限公司 2024-06-28 CN claimed
CN-117471012-A Method for detecting related substances of p-chlorobenzoyl chloride by gas chromatography 南京医科大学康达学院 2024-01-30 CN claimed
CN-114249644-B 2, 4-dichlorobenzoyl chloride production method and tail gas treatment process 江苏万隆化学有限公司 2024-01-30 CN claimed
CN-117342946-A Green treatment process for bis (2, 4-dichlorobenzoyl) peroxide mother liquor 江苏强盛功能化学股份有限公司 2024-01-05 CN claimed
CN-116640056-A Synthesis and byproduct purification method of 2, 4-dichlorobenzoyl chloride 湖北联昌新材料有限公司 2023-08-25 CN claimed
CN-114057710-B Silybin chemical modifier with anti-tumor activity and preparation method thereof 沈阳化工大学 2023-08-01 CN claimed
CN-116375577-A Production process of 2, 4-dichlorotoluene derivative 济源市恒顺新材料有限公司 2023-07-04 CN claimed
US-6369246-B2 ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS DR. KEITH CHAN, GLOBOASIA, LLC 2002-04-09 US claimed
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs CHAN, KEITH 2001-08-30 US claimed
EP-1058679-A1 SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEROF Sloan-Kettering Institute For Cancer Research (US) 2000-12-13 EP claimed
WO-2000061536-A2 SYNTHESIS AND PHARMACEUTICALS OF NOVEL 9-SUBSTITUTED-1,5-DICHLOROANTHRACENE ANALOGS GLOBOASIA, L.L.C. (US) 2000-10-19 WO claimed
WO-1999043653-A1 SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEROF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1999-09-02 WO claimed
EP-0639559-B1 Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines ROHM & HAAS (US) 1997-10-15 EP claimed
CN-1126208-A 2-amido-5-aryl-1,3,4-oxdiazole compound, its synthesis and application HUADONG SCIENCE & ENGINEERING (CN) 1996-07-10 CN claimed
EP-0639559-A1 Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines ROHM AND HAAS COMPANY (US) 1995-02-22 EP claimed
EP-0440329-A1 S-substituted carbonyl substituted betathioacrylamide biocides and fungicides ROHM AND HAAS COMPANY (US) 1991-08-07 EP claimed
US-4847442-A Process for the preparation of difluorobenzenes ALLIED-SIGNAL INC. (US) 1989-07-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12161116-B1 Ethyl-2-{[(2,4-dichlorobenzoyl carbamothioyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as an eco-friendly insecticidal agent against Spodoptera littoralis (boisd.) DDT, L3MBTL4, ABAT SMN1; SMN2 2086/4885TSHR 2013/4885CASP1 375/4885
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs C3AR1, C5AR2, TLR2 SMN1; SMN2 4829/4885TSHR 2549/4885CASP1 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.